全文获取类型
收费全文 | 606篇 |
免费 | 20篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 6篇 |
妇产科学 | 16篇 |
基础医学 | 18篇 |
口腔科学 | 8篇 |
临床医学 | 77篇 |
内科学 | 234篇 |
皮肤病学 | 8篇 |
神经病学 | 57篇 |
特种医学 | 5篇 |
外科学 | 72篇 |
综合类 | 38篇 |
预防医学 | 16篇 |
眼科学 | 2篇 |
药学 | 56篇 |
2篇 | |
中国医学 | 4篇 |
肿瘤学 | 13篇 |
出版年
2023年 | 11篇 |
2022年 | 30篇 |
2021年 | 27篇 |
2020年 | 26篇 |
2019年 | 30篇 |
2018年 | 39篇 |
2017年 | 32篇 |
2016年 | 39篇 |
2015年 | 27篇 |
2014年 | 54篇 |
2013年 | 46篇 |
2012年 | 41篇 |
2011年 | 43篇 |
2010年 | 26篇 |
2009年 | 28篇 |
2008年 | 20篇 |
2007年 | 19篇 |
2006年 | 16篇 |
2005年 | 17篇 |
2004年 | 9篇 |
2003年 | 8篇 |
2002年 | 2篇 |
2001年 | 4篇 |
2000年 | 2篇 |
1999年 | 5篇 |
1998年 | 3篇 |
1997年 | 3篇 |
1996年 | 3篇 |
1995年 | 3篇 |
1994年 | 4篇 |
1993年 | 4篇 |
1992年 | 1篇 |
1990年 | 1篇 |
1989年 | 1篇 |
1988年 | 3篇 |
1987年 | 4篇 |
1986年 | 2篇 |
1985年 | 2篇 |
1982年 | 1篇 |
1976年 | 1篇 |
1974年 | 1篇 |
1973年 | 1篇 |
1970年 | 1篇 |
排序方式: 共有640条查询结果,搜索用时 15 毫秒
1.
《Clinical gastroenterology and hepatology》2022,20(3):e380-e397
- Download : Download high-res image (232KB)
- Download : Download full-size image
2.
Dr. Menon Raj Gopal M.Ch. AlDelamie Taha FRCS Valliathu John FRCS Zacharias Sunny FRCS Lawati Al Adil FRCS Venkatraman M.Ch. 《Indian Journal of Thoracic and Cardiovascular Surgery》2006,22(3):173-177
Background Despite improving surgical techniques, treatment of heart valve disease in children remains controversial. Somatic growth
and adequate anticoagulation are of concern when children undergo valve replacement. We conducted this study to evaluate the
performance of valves in this age group.
Methods 42 children under the age of 13 years who underwent valve replacement were included in this study. Totally, 50 valves were
implanted in 42 patients: 48 were mechanical prostheses, two were bioprosthetic both in pulmonary position. 37 (74%) valves
were implanted in mitral position, 10 (20%) in aortic position, 1 (2%) in tricuspid position and 2 (4%) in pulmonary position.
Preoperatively, 14 (33,3%) patients were in New York Heart Association (NYHA) class IV, while 27 (64.2%) were in NYHA class
III.
Results There were 2 (4.7%) hospital deaths and 2 (4.7%) late deaths while 2 (4.7%) patients were lost to follow up. The mean follow
up period was 9.4 yrs. 35 (83.3%) patients are in NYHA Class I and free of all medications except warfarin. 3 (7.1%) patients
have undergone 5 successful pregnancies. The median INR was 2.23. Major thrombo-embolic episode occurred in 1 (2.3%) patient.
Conclusions In view of the problems of sizing, anticoagulation and need for re-operation at an early age, there is a reluctance to replace
valves in children. This study shows that despite these problems, valve replacement can be undertaken safely and successfully
in children, when repair has failed or not technically feasible. 相似文献
3.
实验表明类肝素碱性处理者在抗凝与降脂上明显优于中性处理者;对小鼠的抗凝作用及TritonWR-1339诱发的大鼠高胆固醇血症的降胆固醇作用,二者在所试剂量范围内随剂量增加作用增强,但对TritonWR-1339性高甘油三酯血症,二者的作用强度未见此效应。 相似文献
4.
5.
目的探讨温度、抗凝剂(EDTA-K2)对血嗜酸性粒细胞阳离子蛋白(ECP)水平的影响。方法采用固相双位点酶放大化学发光法,分别对22例健康体检者在两种不同温度(25℃和37℃)的血清标本,以及在相同温度(37℃)下,加抗凝剂和不加抗凝剂的血标本进行ECP水平测定。结果25℃组和37℃组血清ECP水平分别为8.92±6.45μg/L(x±s)和19.87±12.16μg/L(x±s),两组有显著性差异(P<0.01);37℃温度下加抗凝剂和不加抗凝剂血标本的ECP水平分别为5.26±2.60μg/L(x±s)和19.87±12.16μg/L(x±s),两组也有显著性差异(P<0.001)。结论温度和抗凝剂(EDTA-K2)对血标本的ECP水平测定有不同程度的影响。 相似文献
6.
M. J. Ray P. A. Carroll S. J. E. Just G. A. T. Hawson J. H. N. Belt 《Journal of clinical monitoring and computing》1994,10(2):97-100
Objective. The Ciba Corning 512 coagulation monitor (CC512) can be used to monitor heparin therapy by performing an activated
partial thromboplastin time (APTT) at the patient’s bedside. This study was designed to compare the CC512 results to results
using the laboratory system. The relative sensitivities of both systems to the effect of oral anticoagulant therapy also was
investigated.Methods. Activated partial thromboplastin times were performed with both the CC512 and laboratory system on 74 specimens from patients
receiving IV heparin therapy, and on 14 specimens from patients on warfarin only. Heparin assays were performed on 43 of the
specimens from the heparinized patients.Results. When a patient was receiving heparin only, the APTT results of the CC512 proved to be similar to existing laboratory methods.
The CC512 APTT results of patients on warfarin only were markedly prolonged, whereas the laboratory APTTs were only slightly
affected.Conclusion. The CC512 results were comparable to the laboratory system. However, the CC512 APTT was more sensitive to the effect of
warfarin than the laboratory APTT system used in this study. CC512 APTT results on a patient receiving both oral and intravenous
anticoagulation could be misleading.
The authors wish to thank D.M. O’Brien and the nursing staff of the Coronary Care Unit for providing CC512 data and laboratory
specimens, and I. Smith for the preparation of graphics. We also wish to thank Australian Diagnostics Corporation, which provided
consumables. 相似文献
7.
Summary The purpose of our study was to check whether the dosage recommended for the low molecular weight heparin tested here, i.e., 50% of the corresponding unfractionated heparin dose, is adequate to prevent clot formation in the extracorporeal system. Sixteen dialysis treatments of 4–5 h were given to each of six chronic dialysis patients. In dialyses 1, 2, 15 and 16 unfractionated heparin (initial dose 35 IU/kg, continuous dose 20 IU/kg/h) was given, and in dialyses 3–14 low molecular weight heparin (initial dose 17.5 anti-Xa U/kg, continuous dose 10 anti-X U/kg/h). At these dose levels of low molecular weight heparin, clot formation occurred in the extracorporeal system in five of the six patients, despite the fact that the plasma anti-Xa level of 0.5 U/ml recommended by the manufacturer had been attained. For this reason the continuous dose of low molecular weight heparin had to be raised to approx. 80% of the corresponding continuous dose of unfractionated heparin. A plasma anti-Xa level of 0.7 U/ml is necessary to prevent extracorporeal clot formation.Abbreviations anti-Xa U
Anti-factor Xa unit
- aPTT
Activated partial thromboplastin time
- AT III
Antithrombin III
- IU
International unit
- LMWH
Low molecular weight heparin
- UFH
Unfractionated heparin 相似文献
8.
张运剑 《药物不良反应杂志》2014,(1):30-34
新型抗凝药物主要包括直接凝血酶抑制剂和Xa因子抑制剂。其中,直接凝血酶抑制剂达比加群酯口服制剂、直接Xa因子抑制剂利伐沙班和阿哌沙班口服制剂已在我国上市;另外一种直接Xa因子抑制剂贝曲沙班口服制剂也正在进行Ⅲ期临床研究;而直接Xa因子抑制剂爱多沙班口服制剂已在日本上市。达比加群酯致颅内出血发生风险低于华法林,但该药可能增加急性冠状动脉综合征患者严重出血和具有临床意义轻度出血的发生率,以及心肌梗死或急性冠状动脉综合征的发生风险。利伐沙班在预防非瓣膜性心房颤动所致脑卒中和栓塞方面优于华法林,预防骨科术后血栓效果优于依诺肝素,大出血事件发生风险与两药相似,而颅内出血发生风险低于华法林。阿哌沙班在降低心房颤动患者脑卒中或全身性栓塞发生率及病死率方面优于华法林,颅内出血发生率低于华法林,大出血发生率与华法林相似或降低;阿哌沙班的安全性与用药剂量相关。爱多沙班的主要不良反应为出血,用于心房颤动患者的有效性及安全性均优于华法林。贝曲沙班用于全膝关节置换术后预防血栓效果与依诺肝素相似,出血发生率低于依诺肝素。 相似文献
9.
目的 探讨肠系膜上静脉血栓形成(SWVT)临床特征、诊治方法,研究预后相关因素。方法 回顾性分析华北理工大学附属医院2005~2015年40例肠系膜上静脉血栓形成患者临床资料。结果 主要症状有腹痛、腹胀、发热及呕吐等。40例患者中,29例行单纯抗凝治疗,11例行手术治疗,6例患者30天内死亡。与30天生存率相关的因素为肠切除和确诊前持续时间。结论 该疾病症状不典型,增强CT对诊断具有重要意义,抗凝为基础,保守治疗无效时手术治疗为主要治疗手段,肠切除和确诊前持续时间是影响SMVT 30天生存率相关因素。 相似文献
10.
目的研究围术期应用抗凝及抗血小板药物与起搏器植入术后囊袋血肿形成的关系。方法回顾2007年1月—2010年1月在我院植入或更换起搏器患者的临床资料,在不停用抗凝或抗血小板药物的情况下,对其中血栓高危患者术后囊袋血肿发生情况进行分析。结果共476例患者植入或更换起搏器,有14例出现围术期囊袋血肿并发症,发生率为2.9%,其中服用阿司匹林者6例,双联(阿司匹林联合氯吡格雷)抗血小板者5例,华法林者1例。进一步分析,双联抗血小板药物者血肿发生率较未服用抗凝抗血小板药物者、单用阿司匹林者为高(发生率分别为17.9%,0.7%和4.3%,P<0.05)。所有囊袋血肿经适当处理后好转出院。结论起搏器植入术后囊袋血肿的发生率较低,阿司匹林联合氯吡格雷明显增加起搏器术后囊袋血肿的发生,手术经验和恰当的术中操作有助于减少血肿的发生率。 相似文献